The Prognostic Significance of ‘Stage, Tumor Size, Cellular Atypia and DNA Ploidy in Uterine Leiomyosarcoma
- 1 January 1995
- journal article
- research article
- Published by Taylor & Francis in Acta Oncologica
- Vol. 34 (6) , 797-802
- https://doi.org/10.3109/02841869509127189
Abstract
To analyze the significance of DNA ploidy in uterine leiomyosarcoma, the traditional clinical and histopathological prognostic variables and DNA ploidy were studied in 70 patients with histologically verified uterine leiomyosarcoma. Evaluable flow cytometric DNA histograms from paraffin-embedded tissue from the tumor were obtained in 58 patients. In univariate analysis tumor diameter, FIGO stage and presence of residual disease after primary surgery were highly significant (p < 0.001) and also DNA ploidy (p = 0.043), age (p = 0.017), and menopause status (p = 0.028) obtained significance. Cellular atypia was almost significant (p = 0.056), while mitotic count, malignancy grade and vessel invasion were not. In Cox's multivariate analysis, FIGO-stage was found to be the most important prognostic factor (p <0.001), followed by cellular atypia (p = 0.007) and tumor diameter (p = 0.016). DNA ploidy did not obtain significance when categorized as diploid/non-diploid. Patients with tumors with multiple aneuploid cell populations had a very poor prognosis. When categorized as multiple aneuploidy versus all other ploidy groups, DNA ploidy obtained marginal significance in multivariate analysis (p = 0.054). Tumor diameter, stage and cellular atypia are important prognostic parameters in uterine leiomyosarcomas.Keywords
This publication has 21 references indexed in Scilit:
- Flow Cytometric Analysis of Uterine SarcomasGynecologic Oncology, 1994
- A Multivariate Analysis of Clinicopathologic Factors for Predicting Outcome in Uterine SarcomasGynecologic Oncology, 1994
- Leiomyosarcoma (LMS) and endometrial stromal sarcoma (ESS) of the uterus. A survey of patients treated in the Norwegian Radium Hospital 1976–1985International Journal of Gynecologic Cancer, 1993
- Flow cytometric analysis of uterine sarcoma: Ploidy and S-phase rate as prognostic indicatorsGynecologic Oncology, 1992
- Prognostic Factors Influencing Survival in Gastrointestinal Leiomyosarcomas Implications for Surgical Management and StagingAnnals of Surgery, 1992
- Cellular DNA content as a new prognostic tool in patients with borderline tumors of the ovaryGynecologic Oncology, 1990
- Leiomyosarcoma of the uterus: Clinicopathologic study of 21 casesGynecologic Oncology, 1985
- Convention on nomenclature for DNA cytometryCytometry, 1984
- LEIOMYOSARCOMA OF THE UTERUSObstetrics & Gynecology, 1971
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958